Asymmetrical Graves' disease in children: potential usefulness of potassium iodide monotherapy

BMJ Case Rep. 2022 Apr 22;15(4):e249571. doi: 10.1136/bcr-2022-249571.

Abstract

A male junior high school student presented with failure to gain weight and acceleration of growth for 2 years. Free triiodothyronine and free thyroxine levels were elevated, and the thyroid-stimulating hormone (TSH) level was suppressed. TSH receptor antibody (TRAb) and thyroid-stimulating antibody were negative. On I-123 thyroid scintigraphy, iodine uptake was most pronounced in the upper pole of the right lobe. The patient was initially diagnosed with asymmetrical TRAb-negative Graves' disease (GD). His thyroid hormone level normalised with potassium iodide (KI) alone, and he became TRAb-positive 4 months after the initiation of KI therapy. This case demonstrates a rare presentation of GD that was initially TRAb-negative, which had asymmetrical iodine uptake on a thyroid scan and was confirmed to be TRAb positivity during the follow-up. KI monotherapy could be one of the effective treatment options for GD that is initially TRAb-negative.

Keywords: Endocrine system; Hyperthyroidism; Thyroid disease.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies
  • Child
  • Graves Disease* / diagnosis
  • Graves Disease* / drug therapy
  • Humans
  • Immunoglobulins, Thyroid-Stimulating
  • Male
  • Potassium Iodide* / therapeutic use
  • Thyroid Function Tests
  • Tomography, X-Ray Computed

Substances

  • Autoantibodies
  • Immunoglobulins, Thyroid-Stimulating
  • Potassium Iodide